glutathione peroxidase breast cancer

glutathione peroxidase breast cancer Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of cancer, inhibits progression of breast cells in vitro | Cancer Cell International Glutathione-Dependent Pathways in Cancer Cells

Name: glutathione peroxidase breast cancer Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of cancer, inhibits progression of breast cells in vitro | Cancer Cell International Glutathione-Dependent Pathways in Cancer Cells
Brand: southroadsurgery.com.au
SKU: 83884675834
Price: 28.34 USD
Availability: InStock
Rating: 4.0468 (16 reviews)

Glutathione Dependent Pathways in Cancer Cells Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response Journal for ImmunoTherapy of Cancer High expression of glutathione peroxidase 4 (GPX4) in A J mice after Download Scientific Diagram Antioxidative system and breast cancer Download Scientific Diagram Glutathione peroxidase 4dependent glutathione highconsumption drives acquired platinum chemoresistance in lung cancerderived brain metastasis Liu 2021 Clinical and Translational Medicine Wiley Online Library Extracellular Glutathione Peroxidase GPx3 and Its Role in Cancer

SKU: 83884675834 · From southroadsurgery.com.au

4.0

USD28.34 USD59.34

Pay in 4 interest-free payments of $7.08 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

S.KaranA.ShahriarS

Semin Arthritis Rheum (2014) 43:4708

Depletion of GSH or inactivation of GPX4 leads to LOOH accumulation, resulting in the buildup of toxic peroxidation products, consequent membrane damage, and cell death (29)

Mutations in raf and predominantly in B-raf are responsible for 8% of all cancer types and mutations in MEK have a rather low incidence, less than 1% (Sanchez-Vega et al